Showing results (41-50 of 223) with videos related to

Sort By:
Pageof 23
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I studyLaia Bernet Vegué, Federico Rojo, David Hardisson, et al.
Future Oncology (London, England)|December 8, 2020
PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussionVicente Peg, María Ángeles López-García, Laura Comerma, et al.
The Journal of Pathology. Clinical Research|February 25, 2021
Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancerDavid Gonzalez, Joaquin Mateo, Albrecht Stenzinger, et al.
Cancers|April 3, 2021
Low MicroRNA-19b Expression Shows a Promising Clinical Impact in Locally Advanced Rectal CancerJaime Rubio, Ion Cristóbal, Andrea Santos, et al.
Cancer Cell|February 13, 2007
High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B geneAlejandra Bruna, Rachel S Darken, Federico Rojo, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|May 8, 2026
Expert practical recommendations for optimising tumour and germline testing of homologous recombination repair gene mutations in metastatic prostate cancerPilar González-Peramato, Eugenia García-Fernández, Ana Jambrina, et al.
Cancers|October 13, 2021
Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer PatientsIon Cristóbal, Andrea Santos, Jaime Rubio, et al.
Physiological Reports|August 27, 2025
Effects of presurgical HIIT in hormone receptor-positive, HER 2-negative breast cancer cases: Two case reports from the GEICAM EFiK studyTxomin Pérez-Bilbao, Sara López-Tarruella, María Alonso-Dueñas, et al.
International Journal of Molecular Sciences|October 27, 2022
MicroRNA-19b Plays a Key Role in 5-Fluorouracil Resistance and Predicts Tumor Progression in Locally Advanced Rectal Cancer PatientsAndrea Santos, Ion Cristóbal, Jaime Rubio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targetingPablo Matar, Federico Rojo, Raúl Cassia, et al.
Pageof 23